Skip to main content
. 2021 Apr 2;10(4):792. doi: 10.3390/cells10040792

Figure 9.

Figure 9

Capillary density in gastrocnemius muscle of control (SU5416-control), ADSC (SU5416-ADSC) and hiPSC-SMC (SU5416-hiPSC-SMC) groups with administration of VEGFR2 inhibitor and hiPSC-SMC group with vehicle only (vehicle-hiPSC-SMC) at day 0, 3, 7 and 14. (A), Immunofluorescent isolectin B4 staining of ischemic gastrocnemius. (B), Quantification of capillary density in the ischemic limbs. (two-way ANOVA, p < 0.0001; n = 5, * p < 0.05, ** p < 0.01, **** p < 0.0001 (post-hoc)). -, absence; +, presence.